Zodiac Clothing Q2 loss widens; Rs 15 cr preferential issue to promoters approved

Net loss reportedRevenue declinedResults View source PDF Explain this filing

ZODIACLOTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.1%Reaction day

₹98.02

prior close

₹97.21

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-3.0% vs market

Garments & Apparels peers, median of 37sector-0.5%-2.6% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.6 pts less than its Garments & Apparels peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.5

10m

-0.2

15m

-0.2

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.1-0.1-3.0-0.5-2.6

Next day

-2.5-0.2-2.3-0.6-1.9

-3.0+0.4-3.4-0.8-2.2

-3.1-0.4-2.7-1.1-2.0

-2.9-0.6-2.4-0.1-2.9

-5.1-0.9-4.2-0.5-4.7

-9.6-3.0-6.6-2.9-6.7

15d

-10.0-3.9-6.1-4.6-5.3

-11.4-4.8-6.6-5.5-6.0

-15.2-7.8-7.4-15.0-0.1

-13.9-7.2-6.7-10.6-3.3

UpDownMarket · Nifty Microcap 250Sector · Garments & Apparels peers, median of 37Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zodiac Clothing posted a standalone loss of Rs 1,955 lakhs for H1 FY26 ended September 2025, versus a profit of Rs 2,319 lakhs a year ago. Q2 standalone revenue dropped to Rs 3,634 lakhs from Rs 4,220 lakhs year on year. Consolidated H1 loss stood at Rs 2,113 lakhs. The board approved a Rs 15 crore preferential equity issue to the promoter group, re-appointed Mr S.Y. Noorani as Managing Director for three years, and inducted Mr Mohamed Musaed as an additional director.

Likely market impact

Sustained losses and falling revenue are negatives. Promoter infusion signals confidence but brings dilution. Watch FY26 turnaround closely.